Jump to:
- What Is the Wegovy Maintenance Dose?
- How Long Can You Stay on Wegovy for Weight Maintenance?
- How Is the Right Maintenance Dose Decided?
- How Can You Manage Side Effects During Long-Term Wegovy Treatment?
- What Happens If You Miss a Dose or Need to Stop Wegovy?
- Conclusion: Maintaining Your Wegovy Weight Loss Results
Reaching your target weight does not necessarily mean you need to stop taking Wegovy. Maintaining weight loss can be challenging, and continuing treatment may help manage appetite and reduce the risk of regaining weight. The Wegovy maintenance dose is designed to support ongoing weight management after the initial dose-escalation phase.
However, long-term treatment depends on your progress, how well you tolerate the medication and your individual health needs. Understanding the appropriate maintenance dose, managing potential side effects and knowing when to review your treatment with a healthcare professional can help you make informed decisions about continuing Wegovy.
Wegovy
- ✔ ~16.9% average body weight loss
- ✔ Boosts metabolic & cardiovascular health
- ✔ Proven, long-established safety profile
- ✔ Weekly injection, easy to use
Key Takeaways About Wegovy Maintenance Dose
- The standard UK Wegovy maintenance dose is 2.4 mg weekly after gradual escalation.
- Treatment may continue after reaching your goal weight if clinically appropriate.
- Stopping Wegovy may lead to weight regain, although individual results vary.
- Treatment response, tolerability and overall health guide dose adjustments.
- Smaller meals, hydration and dietary changes help manage gastrointestinal side effects.
- Regular clinical reviews and healthy habits support long-term weight maintenance.
What Is the Wegovy Maintenance Dose?
The Wegovy maintenance dose is the ongoing dose of semaglutide used to support long-term weight management. In the UK, the standard maintenance dose for adults using Wegovy injections is 2.4 mg once weekly, although adjustments may depend on treatment response, tolerability and clinical guidance.
Standard Wegovy Maintenance Dose
Wegovy injections start at 0.25 mg weekly, with the dose gradually increased every four weeks to minimise gastrointestinal side effects.
- Weeks 1–4: 0.25 mg
- Weeks 5–8: 0.5 mg
- Weeks 9–12: 1 mg
- Weeks 13–16: 1.7 mg
- Week 17 onwards: 2.4 mg (maintenance dose)
Eligible adults with obesity may be prescribed 7.2 mg weekly after at least four weeks of 2.4 mg if additional treatment is clinically appropriate.
Lower Maintenance Doses
In the UK, 2.4 mg once weekly is the standard Wegovy maintenance dose, while 1.7 mg is generally used during dose escalation. If significant side effects occur, your prescriber may delay increasing the dose or temporarily reduce it. Adjustments depend on treatment response, tolerability and individual health needs.
Maintenance After Goal Weight
Reaching your target weight does not automatically mean reducing or stopping Wegovy. Continued treatment may help maintain weight loss when benefits outweigh risks. Your clinician should regularly review your progress, side effects and overall health to determine whether your current maintenance dose remains appropriate.
How Long Can You Stay on Wegovy for Weight Maintenance?
Wegovy (semaglutide) may be used as a long-term treatment for weight maintenance, as obesity is a chronic condition that often requires ongoing management. There is no universal maximum treatment duration under UK prescribing guidance, provided Wegovy remains effective, well tolerated and clinically appropriate.
Clinical research supports the benefits of continued treatment:
- STEP 4 trial: Participants continuing semaglutide 2.4 mg weekly lost an additional 7.9% of their body weight over 48 weeks, while those switched to placebo regained an average of 6.9%.
- STEP 1 extension: Participants regained approximately two-thirds of their previous weight loss within a year of stopping semaglutide and structured lifestyle support. Some cardiovascular and metabolic improvements also moved towards their original levels.
These findings highlight the risk of weight regain after stopping treatment, although the extent varies between individuals.
In the UK, NICE limits Wegovy treatment to two years within its specified NHS specialist weight-management pathway, but this restriction does not universally apply to private treatment. Regular clinical reviews remain important after weight stabilisation to assess effectiveness, side effects and overall health, helping your prescriber determine whether continued treatment is appropriate.
How Is the Right Maintenance Dose Decided?
The appropriate Wegovy maintenance dose is determined through an individual clinical assessment rather than automatically choosing the highest strength. Your prescriber considers your weight-loss progress, appetite control, side effects and overall health to develop a suitable long-term treatment plan.
Treatment Response
Your clinician assesses weight changes, appetite, food cravings and improvements in weight-related health conditions. Reaching a stable weight may influence treatment decisions, but the maintenance phase begins after dose escalation, not necessarily after achieving your target weight.
Dose Tolerance and Side Effects
If nausea, vomiting or other side effects become troublesome, your prescriber may delay dose escalation or temporarily reduce the dose. Higher doses should only be considered when clinically appropriate, as stronger treatment is not necessarily suitable for everyone.
Ongoing Monitoring
Maintenance plans may change as your weight, health or treatment response evolves. Your clinician will review progress, side effects, other medications and relevant medical conditions, including kidney health where necessary. UK guidance recommends reviewing treatment benefits and risks if weight loss is below 5% after six months.
Never change your Wegovy dose or injection schedule without medical advice. If you are unsure about your current treatment, an online consultation with a qualified healthcare professional can help assess your progress, manage side effects and review appropriate dose adjustments.
How Can You Manage Side Effects During Long-Term Wegovy Treatment?
Wegovy (semaglutide) commonly causes gastrointestinal side effects, including nausea, vomiting, diarrhoea, constipation and acid reflux. These symptoms often occur when starting treatment or increasing doses and may improve as your body adjusts. Dietary changes, hydration and clinician-guided dose adjustments can help manage discomfort.
Managing Common Side Effects
- Eat smaller meals: Avoid large portions and stop eating when comfortably full.
- Choose lighter foods: Opt for toast, rice, bananas and lean proteins. Limit greasy, spicy or fatty meals if they worsen symptoms.
- Eat slowly: Take smaller bites and remain upright after meals to reduce bloating and acid reflux.
- Stay hydrated: Drink fluids regularly and consider oral rehydration solutions if vomiting or diarrhoea causes fluid loss.
- Relieve constipation: Gradually increase fibre intake, stay active and seek pharmacist advice if symptoms persist.
Recognising Warning Signs
Persistent vomiting or diarrhoea can cause dehydration and kidney problems. Seek medical advice for dizziness, reduced urination or difficulty keeping fluids down. Severe, persistent abdominal pain, particularly spreading to your back, requires urgent assessment for pancreatitis. Upper abdominal pain with fever or jaundice may indicate gallbladder problems.
Reviewing Ongoing Side Effects
If symptoms interfere with eating, hydration or daily activities, contact your prescriber. They may recommend additional symptom management, delaying dose escalation or adjusting your treatment plan. Ongoing side effects should prompt a clinical review rather than being tolerated indefinitely.
What Happens If You Miss a Dose or Need to Stop Wegovy?
Missing a Wegovy (semaglutide) dose or stopping treatment changes the medication levels in your body, potentially affecting appetite control and weight management. The appropriate steps depend on the length of the interruption, your prescribed dose and your overall health.
Managing Missed Doses
According to UK prescribing guidance for Wegovy weekly injections:
- Within 5 days: Take the missed dose as soon as you remember, then resume your usual weekly schedule.
- After 5 days: Skip the missed injection and take your next dose on the scheduled day.
- Multiple missed doses: Contact your prescriber for guidance before restarting treatment.
Never double your dose to compensate for a missed injection. Follow the official UK Wegovy patient leaflet.
Stopping Wegovy Treatment
Semaglutide has a half-life of approximately one week and may remain in your body for around seven weeks after the last 2.4 mg injection. As its effects gradually wear off, appetite and food cravings may increase, potentially leading to weight regain. However, individual responses vary, and weight regain is not inevitable.
Stopping Wegovy does not typically cause withdrawal symptoms or require gradual dose reduction. However, consult your prescriber before stopping, particularly if experiencing side effects or planning pregnancy. Wegovy must be stopped at least two months before conception. A balanced diet, adequate protein and fibre, and regular exercise support weight maintenance.
Restarting After a Break
If you miss two or more consecutive Wegovy injections, your prescriber may recommend restarting at a lower dose to minimise gastrointestinal side effects. Seek medical advice if symptoms return or you feel unwell. Never resume your previous maintenance dose after a prolonged break without consulting your prescriber.
Conclusion: Maintaining Your Wegovy Weight Loss Results
The Wegovy maintenance dose supports long-term weight management by helping control appetite and reduce the risk of weight regain. While 2.4 mg weekly is the standard UK maintenance dose, treatment should reflect your progress, tolerance and health needs. Sustainable results also depend on balanced nutrition and regular physical activity.
Reaching your target weight is an important milestone, but maintaining your progress requires ongoing care and healthy habits. Regular treatment reviews help ensure Wegovy remains appropriate for your needs. London Slimming Clinic provides personalised weight-management support, helping you navigate your treatment journey and work towards sustainable, long-term results.
Mounjaro
- ✔ ~22.5% average body weight loss
- ✔ Significant weight reduction
- ✔ Improves blood sugar levels
- ✔ Clinically proven weight loss
Wegovy
- ✔ ~16.9% average body weight loss
- ✔ Boosts metabolic & cardiovascular health
- ✔ Proven, long-established safety profile
- ✔ Weekly injection, easy to use
FAQs About Wegovy Maintenance Dose
Yes, some people continue losing weight on the Wegovy maintenance dose, while others experience slower progress or reach a plateau. Results depend on individual treatment response, appetite control and lifestyle habits. The maintenance phase does not necessarily mean weight loss has stopped.
A weight-loss plateau can occur as your body adapts to a lower weight. Your prescriber may review your eating habits, physical activity, treatment response and overall health before deciding whether any changes are appropriate.
Yes, you can change your weekly injection day, provided at least three days have passed since your previous injection. Once changed, continue taking Wegovy weekly on your new scheduled day, following the UK patient leaflet.
Wegovy can be injected under the skin of your stomach, thigh or upper arm. Rotate injection sites to reduce irritation, even when using the same body area. Follow the instructions supplied with your prescribed pen.
Unused Wegovy FlexTouch pens should be refrigerated at 2–8°C. Once opened, they can generally be stored below 30°C or refrigerated for up to six weeks. Never freeze Wegovy, and protect the pen from light. Storage instructions may differ between formulations.
Alcohol is not specifically prohibited during Wegovy treatment, but it may worsen nausea, reflux or dehydration. If you choose to drink, limit your intake and monitor symptoms. Speak with your prescriber if you have diabetes or other relevant health conditions.
Wegovy should not be combined with other GLP-1 receptor agonists, such as liraglutide, without appropriate medical guidance. Tell your prescriber about all medicines you take, particularly diabetes treatments, as certain combinations may increase the risk of low blood sugar.
Yes, regular exercise can support weight maintenance and overall health during Wegovy treatment. Combining resistance training with walking or other aerobic activities may help preserve muscle, improve fitness and support sustainable weight management. Choose activities suited to your fitness level and health needs.
UK-based prescribers
GPhC registered pharmacy
UK-based pharmacy
Qualified clinical team
Confidential and discreet delivery